Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hosted on MSN
49m
Viking Therapeutics begins VK2735 Phase II trial for obesity treatment
Scheduled for 13 weeks, the trial will assess the therapy’s safety, tolerability, and efficacy in weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Morning coffee habit study
Man arrested at entrance
Extinction risk research
Israeli hostage found dead
Alito spoke with Trump
Illinois passes Karina's Bill
DOJ sues Pennsylvania city
Grizzly bears stay protected
Peacock president to exit
Military doctor pleads guilty
Hospital workers charged
Teen arrested with a gun
Biden cancels trip to Italy
Ex-FBI informant gets 6 yrs
Ex-police officer sentenced
EC fined for data breach
Massive port strike averted
New Orleans hires Bratton
Changes hate speech rules
Santos' sentencing delayed
Wholesale inventories fall
US withholds WADA dues
Jimmy Carter’s funeral
Russian strike in Ukraine
Clarifies Siri privacy stance
Oscar nominations delayed
Mortgage rate inches up
Lebanon's new president
Related topics
NASDAQ
VK2735
VKTX
Phases of clinical research
Feedback